Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
ImageneBio, Inc. (IMA) had Stock-Based Compensation of $15.39M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-15.38M |
|
-- |
|
-- |
|
$3.11M |
|
$-3.11M |
|
$-7.19M |
|
$-9.50M |
|
$-9.50M |
|
$-9.18M |
|
$-9.18M |
|
$-9.18M |
|
$-9.18M |
|
$-2.31M |
|
$-2.59M |
|
4.87M |
|
4.87M |
|
$-3.85 |
|
$-3.85 |
|
| Balance Sheet Financials | |
$140.29M |
|
-- |
|
$12.69M |
|
$152.98M |
|
$11.23M |
|
-- |
|
$8.60M |
|
$19.84M |
|
$133.14M |
|
$133.14M |
|
$133.14M |
|
11.18M |
|
| Cash Flow Statement Financials | |
$-47.84M |
|
$-5.81M |
|
$135.47M |
|
$12.12M |
|
$94.53M |
|
$82.41M |
|
|
Stock-Based Compensation |
$15.39M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-47.84M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.90% |
|
-6.90% |
|
-6.00% |
|
-6.90% |
|
$11.91 |
|
$-9.82 |
|
$-9.82 |
|